Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare...

Global Med Technologies(R) Licenses Transfusion Software Solution to
Nationwide Healthcare System

40+ Hospital Organization Serves Growing Non-Urban Market Segments

DENVER, June 16 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international
healthcare information technology company, today announced that its Wyndgate
Technologies(R) division has licensed its SafeTrace Tx(R) transfusion
management software to a 40+ hospital healthcare system. The organization
will also be contracting validation services, another cost-effective business
solution, from Global Med's PeopleMed subsidiary. Terms of the agreement were
not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

SafeTrace Tx is transfusion management software which provides comprehensive
tracking of orders, specimens, blood products, derivatives, and accessories
with a complete testing and transfusion history in one consolidated record.
These powerful features will assist the hospital healthcare system's staff in
selecting appropriate blood products for their patients and help to reduce
waste and increase efficiency in their blood banks.

Thomas F. Marcinek, President and COO of Global Med Technologies, Inc.,
stated, "Large healthcare organizations, both domestically and
internationally, are increasingly selecting Global Med companies as their
vendor of choice. We believe this is a result of several positive factors:
Global Med's ability to meet the needs of our customers, our reputation,
financial stability, and capacity to partner valued relationships with top
laboratory and hospital information system vendors."

Mr. Marcinek continued, "We are pleased to have been chosen by this growing
organization to implement our SafeTrace Tx transfusion management system in
their hospitals. We appreciate their confidence in our ability to deliver
quality business solutions and to develop a streamlined implementation plan."

About Global Med Technologies(R), Inc.
Global Med Technologies, Inc. is an international healthcare information
technology company which develops regulated and non-regulated products and
services for the healthcare industry. As a leading provider of blood and
laboratory systems and services, Global Med's products are deployed in 20
countries and serve over 2,100 transfusion centers, blood banks and laboratory
sites.

Global Med's domestic companies are Wyndgate Technologies(R), a leader in
software products and services for donor centers and hospital transfusion
services; eDonor(R), which offers web-based donor relationship management
systems; and PeopleMed(TM), Inc., which implements cost-effective software
validation, consulting and compliance solutions to hospitals and donor
centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor
center and transfusion management systems as well as cellular therapy
software, laboratory information systems and quality assurance medical
software systems internationally.

For more information about Global Med's products and services, please call
800-996-3428 or visit www.globalmedtech.com.

This news release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of
1995. Forward-looking statements inherently involve risks and uncertainties
that could cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or changes
after the date of this news release.

SOURCE Global Med Technologies, Inc.

Company, Michael I. Ruxin, M.D., +1-303-238-2000, mick@globalmedtech.com, or
Investors, Karen Davis, CFO, +1-916-404-8495, davisk@globalmedtech.com, both
of Global Med Technologies, Inc.